Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ANGIOTECH PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
VIA Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ANGIOTECH PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ANGIOTECH PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ANGIOTECH PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ANGIOTECH PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ANGIOTECH PHARMACEUTICALS INCListing unverified | Buy | $7.8K | conv 83First in 12mo | SEC | |
ANGIOTECH PHARMACEUTICALS INCListing unverified | Buy | $200 | conv 41First in 12mo | SEC | |
ANGIOTECH PHARMACEUTICALS INCListing unverified | Buy | $200 | conv 70First in 12mo | SEC | |
ANGIOTECH PHARMACEUTICALS INCListing unverified | Buy | $7.8K | conv 83First in 12mo | SEC | |
VIA Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
VIA Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $77.2K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $3.6K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $359 | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $1.4K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $5.3K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Exercise | $15.8K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $6.9K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $16.9K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $2.3K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $4.7K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $389 | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Sell | $19.4K | SEC |